发明名称 |
Pharmaceutical compositions comprising sorbitan esters |
摘要 |
The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs. |
申请公布号 |
US9351976(B2) |
申请公布日期 |
2016.05.31 |
申请号 |
US201514714621 |
申请日期 |
2015.05.18 |
申请人 |
ALKERMES PHARMA IRELAND LIMITED |
发明人 |
Perry Jason M.;Deaver Daniel R.;Hickey Magali B.;Remenar Julius F.;Vandiver Jennifer |
分类号 |
A61K31/551;A61K9/00;A61K47/26;A61K31/5513;A61K31/4965;A61K31/497;A61K9/10;A61K31/496 |
主分类号 |
A61K31/551 |
代理机构 |
Lathrop & Gage LLP |
代理人 |
Lathrop & Gage LLP ;Trinque Brian C.;Heuberger Benjamin D. |
主权项 |
1. A pharmaceutical composition comprising:
(a) compound of Formula (III) or (IV): wherein R3 is—CH2OC(O)R1, —CH2OC(O)OR1, —CH2OC(O)N(R1)2 or —C(O)R1; R4 is—CH2OC(O)R1, —CH2OC(O)OR1, —CH2OC(O)N(R1)2 or —C(O)R1; wherein each R1 is independently selected from the group consisting of hydrogen, substituted or unsubstituted aliphatic, and substituted or unsubstituted aryl; and wherein Y⊖is a pharmaceutically acceptable counterion; (b) sorbitan laurate; (c) polysorbate 20; and (d) an aqueous vehicle wherein the composition forms an aqueous, flocculated, injectable suspension. |
地址 |
Dublin IE |